Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Daniel John Renouf"'
Autor:
Claire Friedman, Richard Carvajal, Diwakar Davar, Eduardo Castanon, Paolo Ascierto, Emiliano Calvo, Mark O'Hara, Steven Powell, Ronnie Shapira-Frommer, Elena Garralda, Daniel John Renouf, Ruth Perets, Mona Yunan, Palanikumar Ravindran, Amy Hammell, Shaun O’Brien, Ke Xu, Nicholas Wilson, Amy Jhatakia, Anandaroop Mukhopadhyay, Martin Gutierrez
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::166c628781ac35a6e708c43ad76057ad
https://doi.org/10.1136/jitc-2022-sitc2022.0592
https://doi.org/10.1136/jitc-2022-sitc2022.0592
Autor:
Erica S Tsang, James T. Topham, Joanna Karasinska, Steve Kalloger, Veronika Csizmok, Laura Williamson, Hui-Li Wong, Grainne M. O'Kane, Jonathan M. Loree, Faiyaz Notta, Oliver F. Bathe, Patricia A. Tang, Rachel Anne Goodwin, Jennifer J. Knox, Steven Gallinger, Janessa J. Laskin, Marco A. Marra, Steven J. M. Jones, David F. Schaeffer, Daniel John Renouf
Publikováno v:
Journal of Clinical Oncology. 40:587-587
587 Background: Oncogenic driver mutations in KRAS represent a hallmark genomic event in approximately 90% of pancreatic adenocarcinoma (PDAC). For the remaining 10% of patients with KRAS wildtype (wt) PDAC, distinct driver mutations have been descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31b292cea8d9566496d8211ad954d201
https://doi.org/10.1200/jco.2022.40.4_suppl.587
https://doi.org/10.1200/jco.2022.40.4_suppl.587
Autor:
Deirdre Kelly, Derek J. Jonker, Yoo-Joung Ko, Paul Jack Karanicolas, Kimberly A. Bertens, Shiva Jayaraman, Jad Abou-Khalil, Carol-Anne Moulton, Michael J. Raphael, Melanie Tsang, Stephen Welch, Petr Kavan, Jim Biagi, Daniel John Renouf, Sandra Fischer, Sangeetha Kalimuthu, Korosh Khalili, Anna Dodd, Steven Gallinger, Jennifer J. Knox
Publikováno v:
Journal of Clinical Oncology. 40:TPS638-TPS638
TPS638 Background: Prospective studies of the benefit of neoadjuvant chemotherapy in resectable pancreatic adenocarcinoma (PDAC) have been reported. The ideal peri-operative regimen is yet to be determined. Adjuvant FOLFIRINOX (mFFX) in resected PDAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10032c1378ea619f8dd55a24d60c1ca5
https://doi.org/10.1200/jco.2022.40.4_suppl.tps638
https://doi.org/10.1200/jco.2022.40.4_suppl.tps638
Autor:
Manik Chahal, Howard John Lim, Janine Marie Davies, Jonathan M. Loree, Daniel John Renouf, Sharlene Gill
Publikováno v:
Journal of Clinical Oncology. 39:e16236-e16236
e16236 Background: In recent years adjuvant therapy (AT) options for pancreatic cancer have evolved. Compared to gemcitabine (Gem) alone, improved overall survival (OS) was demonstrated first in 2017 with gemcitabine and capecitabine (GemCap), and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21257f9200f63cac1c1eccbff7460bdd
https://doi.org/10.1200/jco.2021.39.15_suppl.e16236
https://doi.org/10.1200/jco.2021.39.15_suppl.e16236
Publikováno v:
Journal of Clinical Oncology. 35:e18163-e18163
e18163 Background: No standard surveillance strategy exists following resection of pancreas cancer. Our aims were to describe patterns of surveillance and to evaluate their impact on outcomes. Methods: Patients who received at least one cycle of adju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9470db430cf313b53f90821b783f2a82
https://doi.org/10.1200/jco.2017.35.15_suppl.e18163
https://doi.org/10.1200/jco.2017.35.15_suppl.e18163
Autor:
Hui-Li Wong, Kevin Bushell, Joanna Karasinska, Sarah Arthur, Ryan Morin, David F. Schaeffer, Daniel John Renouf
Publikováno v:
Journal of Clinical Oncology. 34:e23043-e23043
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f684c7ac8f13518703c8242649f62a12
https://doi.org/10.1200/jco.2016.34.15_suppl.e23043
https://doi.org/10.1200/jco.2016.34.15_suppl.e23043
Autor:
Daniel John Renouf, Joanna Karasinska, Steve Kalloger, Setareh Samimi, Renata Peixoto, Kate O'Connor, David Schaeffer
Publikováno v:
Journal of Clinical Oncology. 33:e15216-e15216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c89fb63394f25eebfaff8082e9721d06
https://doi.org/10.1200/jco.2015.33.15_suppl.e15216
https://doi.org/10.1200/jco.2015.33.15_suppl.e15216